Insulin mimetic effect of tungsten compounds on isolated rat adipocytes

Biological Trace Element Research

Volumn 134, Issue 3, 2010, Pages 296-306

  Topic, Aleksandra ^a,b   Milenkovic, Marina ^a   Uskokovic Markovic, Snezana ^a   Vucicevic, Dragana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Biochemistry   (Serbia)

Author keywords

Adipocytes; Dimethyl sulfoxide; Insulin mimetic; Tungsten compounds

Indexed keywords

ADRENALIN; DIMETHYL SULFOXIDE; FATTY ACID; INSULIN; PHOSPHOTUNGSTIC ACID; PHOSPHOTUNGSTIC ACID ALANINE; SODIUM CHLORIDE; TUNGSTATE SODIUM; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FAT INTAKE; GLUCOSE TRANSPORT; MALE; NONHUMAN; RAT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; INSULIN; MALE; MOLECULAR MIMICRY; RATS; RATS, WISTAR; TUNGSTEN COMPOUNDS;

RATTUS;

EID: 77951939552     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8474-y     Document Type: Article

References (44)

1. Delgado O, Dress A, Müller A, Pope MT (1994) Polyoxometalates: a class of compounds with remarkable topology. In: Pope MT, Müller A (eds) Polyoxometalates: from platonic solids to anti-retroviral activity. Kluwer Academic, Dordrecht
2. J Rhule C Hill D Judd R Schinazi 1998 Polyoxometalates in medicine Chem Rev 98 327 357 10.1021/cr960396q 1:CAS:528:DyaK1cXotVShtQ%3D%3D 11851509
3. D Rehder 1999 The coordination chemistry of vanadium as related to its biological functions Coord Chem Rev 182 297 322 10.1016/S0010-8545(98)00194-5
4. M Jelikic Stankov S Uskokovic Markovic I Holclajtner Antunovic M Todorovic P Djurdjevic 2007 Compounds of Mo, V and W in biochemistry and their biomedical activity J Trace Elem Med Biol 21 8 16 10.1016/j.jtemb.2006.11.004 1:CAS:528:DC%2BD2sXltFWjsbY%3D 17317520
5. PJ Stankiewicz MJ Gresser 1988 Inhibition of phosphatase and sulfatase by transition-state analogues Biochemistry 27 206 212 10.1021/bi00401a031 1:CAS:528:DyaL1cXltFynug%3D%3D 3280015
6. G Soman YC Chang DJ Graves 1983 Effect of oxyanions of the early transition metals on rabbit skeletal muscle phosphorylase Biochemistry 22 4994 5000 10.1021/bi00290a018 1:CAS:528:DyaL3sXltlKjs74%3D 6416293
7. J Matsumoto 1994 Vanadate, molybdate and tungstate for orthomolecular medicine Med Hypotheses 43 177 182 10.1016/0306-9877(94)90149-X 1:STN:280:DyaK2M7hsFGruw%3D%3D 7815975 (Pubitemid 24305294)
8. JM Fessenden-Raden 1971 Effect of silicotungstate on reduced diphosphopyridine nucleotide oxidation in submitochondrial particles J Biol Chem 246 6745 6749 1:CAS:528:DyaE38Xkt1aitw%3D%3D 4331194
9. RM Pitt TG McKelvey JS Saenger AK Shah HP Jones AE Manci RW Powell 1991 A tungsten-supplemented diet delivered by transplacental and breast-feeding routes lowers intestinal xanthine oxidase activity and affords cytoprotection in ischemia-reperfusion injury to the small intestine J Pediatr Surg 26 930 935 10.1016/0022-3468(91)90839-L 1:STN:280:DyaK38%2FhsVKitA%3D%3D 1919986
10. PL Hwang RJ Ryan 1981 Tungstate stimulates adenylate cyclase Endocrinology 108 435 439 10.1210/endo-108-2-435 1:CAS:528:DyaL3MXnvFagug%3D%3D 7449732
11. JD Foster SE Young TD Brandt RC Nordlie 1998 Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase Arch Biochem Biophys 354 125 132 10.1006/abbi.1998.0695 1:CAS:528:DyaK1cXjvFSitbc%3D 9633606 (Pubitemid 28372992)
12. A Barbera JE Rodriguez-Gil JJ Guinovart 1994 Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism J Biol Chem 269 20047 20053 1:CAS:528:DyaK2cXlt1Cqt78%3D 8051090
13. A Barbera J Fernandez-Alvarez A Truc R Gomis JJ Guinovart 1997 Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia Diabetologia 40 143 149 10.1007/s001250050655 1:CAS:528:DyaK2sXhtFaqsLY%3D 9049473 (Pubitemid 27060285)
14. A Barbera RR Gomis N Prats JE Rodriguez-Gil M Domingo R Gomis JJ Guinovart 2001 Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study Diabetologia 44 507 513 10.1007/s001250100479 1:CAS:528:DC%2BD3MXit1Giur4%3D 11357483 (Pubitemid 32324363)
15. JE Domínguez MC Muñoz D Zafra I Sánchez-Pérez S Baqué M Caron C Mercurio A Barberà R Perona R Gomis JJ Guinovart 2003 The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway J Biol Chem 278 42785 42794 10.1074/jbc.M308334200 12925525 (Pubitemid 37345888)
16. S Barcelo-Batllori H Corominola M Claret I Canals J Guinovart R Gomis 2005 Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats Proteomics 5 4927 4935 10.1002/pmic.200500050 1:CAS:528:DC%2BD28Xktlemug%3D%3D 16267817 (Pubitemid 43016911)
17. M Claret H Corominola I Canals J Saura S Barcelo-Batllori JJ Guinovart R Gomis 2005 Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation Endocrinology 146 4362 4369 10.1210/en.2005-0385 1:CAS:528:DC%2BD2MXhtVGmurbK 16002523 (Pubitemid 41324032)
18. S Barcelo-Batllori SG Kalko Y Esteban S Moreno MC Carmona R Gomis 2008 Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue Proteomics 7 378 393 1:CAS:528:DC%2BD1cXitlyltrk%3D
19. Uskokovic-Markovic S, Milenkovic M, Topic A, Kotur-Stevuljevic J, Stefanovic A, Antic-Stankovic J (2007) Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats. J Pharm Pharmaceut Sci 10:340-349
20. S Pawa SS Ali 2004 Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten Biochim Biophys Acta 1688 210 222 1:CAS:528:DC%2BD2cXivVGhtL8%3D 15062871
21. MD Giron JJ Caballero AM Vargas MD Suarez JJ Guinovart R Salto 2003 Modulation of glucose transporters in rat diaphragm by sodium tungstate FEBS Lett 542 84 88 10.1016/S0014-5793(03)00352-1 1:CAS:528:DC%2BD3sXjt1OhtLk%3D 12729903 (Pubitemid 36555719)
22. MC Muñoz A Barberà J Domínguez J Fernàndez- Alvarez R Gomis JJ Guinovart 2001 Effects of tungstate, a new potential oral antidiabetic agent, in zucker diabetic fatty rats Diabetes 50 131 138 10.2337/diabetes.50.1.131 11147778
23. J Rodriguez-Gallardo RA Silvestre EM Egido J Marco 2000 Effects of sodium tungstate on insulin and glucagon secretion in the perfused rat pancreas Eur J Pharmacol 402 199 204 10.1016/S0014-2999(00)00492-1 1:CAS:528: DC%2BD3cXlsFCgu7k%3D 10940374 (Pubitemid 30625327)
24. RA Silvestre EM Egido R Hernández J Marco 2005 Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas Eur J Pharmacol 519 127 134 10.1016/j.ejphar.2005.06.028 1:CAS:528:DC%2BD2MXpslymsrk%3D 16126195 (Pubitemid 43181175)
25. S Piquer S Barceló-Batllori M Julià N Marzo B Nadal JJ Guinovart R Gomis 2007 Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells Biochem Biophys Res Commun 358 385 391 10.1016/j.bbrc.2007.04.143 1:CAS:528:DC%2BD2sXlsFKgt7w%3D 17490618 (Pubitemid 46778909)
26. J Li G Elberg J Libman A Shanzer D Cefel Y Shechter 1995 Insulin-like effects of tungstate and molybdate: mediation through insulin receptor independent pathways Endocrine 3 631 637 10.1007/BF02746339 1:CAS:528: DyaK2MXotleqtb8%3D
27. HN Mukherjee 1936 Hypoglycaemic and other actions of phosphotungstic acid, phosphomolybdic acid and allied substances Biochem J 30 1583 1585 1:CAS:528:DyaA2sXosVSj 16746195
28. K Nomiya H Torii T Hasegawa Y Nemoto K Nomura K Hashino M Uchida Y Kato K Shimizu M Oda 2001 Insulin mimetic effect of a tungstate cluster. Effect of oral administration of homo-polyoxotungstates and vanadium-substituted polyoxotungstates on blood glucose level of STZ mice J Inorg Biochem 86 657 667 10.1016/S0162-0134(01)00233-1 1:CAS:528:DC%2BD3MXnt1Wiu7Y%3D 11583783 (Pubitemid 32907291)
29. I Holclajtner-Antunovic D Bajuk-Bogdanovic M Todorovic U Mioc J Zakrzewska S Uskokovic-Markovic 2008 Sectroscopic study of stability and molecular species of 12-tungstophosphoric acid in aqueous solution Can J Chem 86 996 1004 10.1139/V08-138 1:CAS:528:DC%2BD1cXht12lt7rO
30. H Sakurai K Fujii H Watanabe H Tamura 1995 Orally active and long-term acting insulin mimetic vanadyl complex:bis(picolinato)oxovanadium (IV) Biochem Biophys Res Commun 214 1095 1101 10.1006/bbrc.1995.2398 1:CAS:528: DyaK2MXot1yht7s%3D 7575515
31. M Rodbell 1964 Metabolism of Isolated Fat Cells I. Effects of hormones on glucose metabolism and lipolysis J Biol Chem 239 375 380 1:CAS:528: DyaF2cXjt1GhsQ%3D%3D 14169133
32. Kozhevnikov IV (2002) Synthesis of Polyoxometalates. In: Kozhevnikov IV (ed) Catalysts for fine chemical synthesis, catalysis by polyoxometalates (catalysts for fine chemicals synthesis), vol 2. Wiley and Sons, England, p 51
33. V Kuntic I Holclajtner-Antunovic S Uskokovic-Markovic U Mioc M Todorovic M Stanojevic V Vukojevic 2006 Synthesis, characterization and biological activity of aminoacid substituted heteropoly tungstophosphate acid Monatsch Chem 137 803 810 10.1007/s00706-006-0467-3 1:CAS:528:DC%2BD28XlsV2jsrY%3D (Pubitemid 43873710)
34. WT Hron LA Menahan 1981 A sensitive method for the determination of free fatty acids in plasma J Lipid Res 22 377 381 1:CAS:528:DyaL3MXhslSntbo%3D 7240964
35. P Trinder 1969 Determination of glucose in blood using glucose oxidase with an alternativeoxygen acceptor Ann Clin Biochem 6 24 28 1:CAS:528: DyaE3MXotl2itA%3D%3D
36. DM Smith RM Pickering GT Lewith 2008 A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus QJM 101 351 358 10.1093/qjmed/hcn003 1:STN:280:DC%2BD1c3ntVegsQ%3D%3D 18319296 (Pubitemid 351619242)
37. JL Domingo 2002 Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects Biol Trace Elem Res 88 97 112 10.1385/BTER:88:2:097 1:CAS:528:DC%2BD38XnsFentrw%3D 12296430
38. CL Hill MS Weeks RF Schinazi 1990 Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates J Med Chem 33 2767 2772 10.1021/jm00172a014 1:CAS:528:DyaK3cXls1Cqtro%3D 2213829
39. PB Wieser MA Zeiger JN Fain 1977 Effects of dimethylsulfoxide on cyclic AMP accumulation, lipolysis and glucose metabolism of fat cells Biochem Pharmacol 26 775 778 10.1016/0006-2952(77)90223-4 1:CAS:528:DyaE2sXkvFKkurs%3D 193516 (Pubitemid 8081533)
40. KH Kolb G Janicke M Kramer PE Schulze G Raspe 1967 Absorption, distribution and elimination of labeled dimethyl sulfoxide in man and animals Ann NY Acad Sci 141 85 95 10.1111/j.1749-6632.1967.tb34869.x 1:CAS:528:DyaF2sXkt1SntL8%3D 5232278
41. SL Lamer G Cros C Pinol J Fernandez-Alvarez F Bressolle 2002 An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats Pharmacol Toxicol 90 100 105
42. SL Lamer G Cros JJ Serrano C Pinol J Fernandez-Alvarez F Bressolle 2001 Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dogs Eur J Pharm Sci 14 323 329 10.1016/S0928-0987(01)00185-3 11684407 (Pubitemid 33001625)
43. SL Lamer-Dechamps P Poucheret G Cros F Bressolle 2002 Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat Int J Pharm 248 131 139 10.1016/S0378-5173(02)00424-6 12429467 (Pubitemid 35341417)
44. J Fernandez-Alvarez A Barbera B Nadal S Barcelo-Batllori S Piquer M Claret JJ Guinovart R Gomis 2004 Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate Diabetologia 47 470 477 10.1007/s00125-004-1332-8 1:CAS:528:DC%2BD2cXis1Ggtr8%3D 14968293 (Pubitemid 38491243)